Pharma-Bio Serv Inc (PBSV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 10-2024 | 10-2023 | 10-2022 | 10-2021 | 10-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -778 | 1,310 | 1,007 | -2,089 | 2,051 |
| Depreciation Amortization | 181 | 194 | 188 | 73 | 86 |
| Accounts receivable | 1,457 | 1,093 | -463 | -135 | -944 |
| Other Working Capital | 228 | 662 | -674 | -518 | -652 |
| Other Operating Activity | -1,655 | -1,368 | 535 | 3,474 | 974 |
| Operating Cash Flow | $-567 | $1,891 | $593 | $805 | $1,514 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,201 | -4,211 | N/A | N/A | N/A |
| PPE Investments | -160 | -7 | -19 | 47 | -29 |
| Other Investing Activity | 0 | 0 | 0 | 1,250 | 0 |
| Investing Cash Flow | $-1,361 | $-4,218 | $-19 | $1,297 | $-29 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 1,932 |
| Common Stock Repurchased | -11 | -34 | -82 | -26 | -2 |
| Dividend Paid | -1,722 | -1,724 | -3,447 | -1,727 | -1,725 |
| Financing Cash Flow | $-1,734 | $-1,758 | $-3,529 | $-1,753 | $205 |
| Exchange Rate Effect | -18 | 69 | -50 | -18 | -42 |
| Beginning Cash Position | 10,446 | 14,463 | 17,468 | 17,138 | 15,490 |
| End Cash Position | 6,767 | 10,446 | 14,463 | 17,468 | 17,138 |
| Net Cash Flow | $-3,679 | $-4,017 | $-3,006 | $330 | $1,648 |
| Free Cash Flow | |||||
| Operating Cash Flow | -567 | 1,891 | 593 | 805 | 1,514 |
| Capital Expenditure | -160 | -7 | -19 | -11 | -56 |
| Free Cash Flow | -726 | 1,884 | 573 | 794 | 1,459 |